Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01072981 | Immunotherapy Study for Surgically Resected Pancreatic Cancer | completed | Phase 3 | 722 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT03829748 | Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions | completed | N/A | 33 | Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT02777463 | The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.(DIFFERENT) | completed | — | 28 | Wakayama Medical UniversityOTHER | 1 | May 20, 2020 | clinicaltrials |
| NCT04395898 | Pancreaticoduodenectomy: Outcomes of a Complex Surgical Procedure From a Developing Country | completed | — | 161 | Shaukat Khanum Memorial Cancer Hospital & Research CentreOTHER | 1 | May 20, 2020 | clinicaltrials |
| NCT01896869 | FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer | completed | Phase 2 | 83 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT02261714 | Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer | completed | Phase 1 / Phase 2 | 32 | Targovax ASAINDUSTRY | 3 | May 14, 2020 | clinicaltrials |
| NCT01643499 | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | completed | Phase 1 | 79 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02115022 | EUS vs. MDCT in Pancreatic Malignancy(EUSPACT) | completed | — | 45 | Clinical Hospital ColentinaOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT02628860 | Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy(FCM) | completed | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 28, 2020 | clinicaltrials |
| NCT03494023 | EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice(ECCO) | completed | — | 539 | Clinical Hospital ColentinaOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | completed | Phase 2 | 19 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 27, 2020 | clinicaltrials |
| NCT04361682 | Preoperative Inflammatory Biomarkers and Postoperative Day 1 Drain Amylase Value Predict Pancreatic Fistula After Pancreaticoduodenectomy | completed | — | 227 | Campus Bio-Medico UniversityOTHER | 0 | Apr 24, 2020 | clinicaltrials |
| NCT02691052 | Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program(QoliXane) | completed | — | 600 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT00077519 | Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 1 | 18 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 15, 2020 | clinicaltrials |
| NCT00454363 | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00026338 | Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer | completed | Phase 3 | 569 | NCIC Clinical Trials GroupNETWORK | 19 | Apr 2, 2020 | clinicaltrials |
| NCT02101918 | Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Mar 23, 2020 | clinicaltrials |
| NCT01677312 | Trial Comparing 19 and 25-gauge EUS-FNA Needles(EUS-FNA) | completed | N/A | 72 | AdventHealthOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT04133155 | Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer | completed | — | 103 | Asan Medical CenterOTHER | 1 | Mar 13, 2020 | clinicaltrials |
| NCT02681796 | Epidural Analgesia Use in Pancreatic Resections(E-PRO I) | completed | Phase 1 | 23 | Washington University School of MedicineOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT01693523 | Minocycline Study in Pancreatic Cancer Patients | completed | Phase 2 | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 9, 2020 | clinicaltrials |
| NCT03515356 | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy | completed | N/A | 54 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 9, 2020 | clinicaltrials |
| NCT01473940 | Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 21 | Northwestern UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT03949933 | Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer | completed | N/A | 10 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT03869294 | GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients | completed | — | 96 | Zhejiang UniversityOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT00727441 | Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery | completed | Phase 2 | 87 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT00836407 | Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 24, 2020 | clinicaltrials |
| NCT00305760 | Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT01346410 | Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer | completed | N/A | 1 | Mercy ResearchOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT00439179 | A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema(BrUOG-PA205) | completed | Phase 1 | 27 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01744353 | BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study(278) | completed | Phase 1 | 35 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT02238847 | Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy | completed | N/A | 119 | Boston Scientific CorporationINDUSTRY | 6 | Feb 17, 2020 | clinicaltrials |
| NCT01438476 | Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas | completed | Phase 3 | 178 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT03267966 | Margin Status After Pancreaticoduodenectomy for Cancer | completed | N/A | 168 | Campus Bio-Medico UniversityOTHER | 0 | Feb 6, 2020 | clinicaltrials |
| NCT02559674 | QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel | completed | Phase 1 | 8 | Altor BioScienceINDUSTRY | 1 | Jan 27, 2020 | clinicaltrials |
| NCT01846520 | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | completed | N/A | 200 | City of Hope Medical CenterOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT03307148 | Stromal TARgeting for PAncreatic Cancer (STAR_PAC)(STAR_PAC) | completed | Phase 1 | 29 | Barts & The London NHS TrustOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02079623 | Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer(NanoKnife) | completed | — | 33 | Aalborg University HospitalOTHER | 1 | Jan 10, 2020 | clinicaltrials |
| NCT02358161 | Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer(MATRIX) | completed | Phase 1 / Phase 2 | 78 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT01488513 | ABC294640 in Treating Patients With Advanced Solid Tumors(ABC-101) | completed | Phase 1 | 22 | RedHill Biopharma LimitedINDUSTRY | 1 | Jan 7, 2020 | clinicaltrials |
| NCT02678442 | Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle | completed | N/A | 50 | Mayo ClinicOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT03811652 | A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors | completed | Phase 1 | 8 | MedImmune LLCINDUSTRY | 2 | Dec 30, 2019 | clinicaltrials |
| NCT02541370 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 | completed | Phase 1 / Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT03578445 | Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions | completed | N/A | 101 | Herlev HospitalOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT00844649 | Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas | completed | Phase 3 | 861 | CelgeneINDUSTRY | 11 | Nov 25, 2019 | clinicaltrials |
| NCT02749136 | Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer | completed | Phase 2 | 44 | Asan Medical CenterOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT00398086 | Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 67 | CelgeneINDUSTRY | 1 | Nov 22, 2019 | clinicaltrials |
| NCT02981342 | A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma | completed | Phase 2 | 106 | Eli Lilly and CompanyINDUSTRY | 8 | Nov 20, 2019 | clinicaltrials |
| NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | completed | Phase 2 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 13, 2019 | clinicaltrials |
Data updated 23 days agoSource updated May 28, 2020source: clinicaltrials